Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI)
This study is currently recruiting participants.
Verified January 2013 by Amneal Pharmaceuticals, LLC
Sponsor:
Amneal Pharmaceuticals, LLC
Collaborator:
Symbio, LLC
Information provided by (Responsible Party):
Amneal Pharmaceuticals, LLC
ClinicalTrials.gov Identifier:
NCT01650051
First received: July 19, 2012
Last updated: January 9, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | April 2013 |
| Estimated Primary Completion Date: | February 2013 (Final data collection date for primary outcome measure) |